Case number 1:22-cv-00945
Exelixis, Inc. v. MSN Laboratories Private Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Aug 23, 2022 | 12 | SO ORDERED Granting (D.I. 34 in 22-cv-228-RGA-JLH; D.I. 11 in 22-cv-945-RGA) Stipulation and Proposed Order to Consolidate Action. Signed by Judge Richard G. Andrews on 8/23/2022. Associated Cases: 1:22-cv-00228-RGA-JLH, 1:22-cv-00945-RGA(nms) (Entered: 08/23/2022) (2) |
| Aug 19, 2022 | 11 | STIPULATION and [Proposed] Order to Consolidate Action by Exelixis, Inc.. (Raucci, Anthony) (Entered: 08/19/2022) (2) |
| Aug 9, 2022 | 9 | ANSWER to 1 Complaint, and COUNTERCLAIMS against All Plaintiffs, by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc..(Gattuso, Dominick) Modified on 8/10/2022 (nms). (Entered: 08/09/2022) (15) |
| Aug 9, 2022 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent MSN Laboratories Private Limited for MSN Pharmaceuticals, Inc. filed by MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc.. (Gattuso, Dominick) (Entered: 08/09/2022) (1) |
| Jul 20, 2022 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 19, 2022 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Exelixis, Inc.. MSN Laboratories Private Limited served on 7/19/2022, answer due 8/9/2022. (Raucci, Anthony) |
| Jul 19, 2022 | 8 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Exelixis, Inc.. MSN Pharmaceuticals, Inc. served on 7/19/2022, answer due 8/9/2022. (Raucci, Anthony) |
| Jul 18, 2022 | 1 | Main Document (9) Docket Text: COMPLAINT for PATENT INFRINGEMENT - filed against MSN Laboratories Private Limited, MSN Pharmaceuticals, Inc. ( Filing fee $ 402, receipt number ADEDC-3917357.) - filed by Exelixis, Inc. (Attachments: # (1) Exhibit A, # (2) Civil Cover Sheet)(smg) |
| Jul 18, 2022 | 1 | Exhibit A (20) |
| Jul 18, 2022 | 1 | Civil Cover Sheet (1) |
| Jul 18, 2022 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Jul 18, 2022 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: On or about June 7, 2022. Date of Expiration of Patent: 02/10/2032. (smg) |
| Jul 18, 2022 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,298,349 B2. (smg) |
| Jul 18, 2022 | 5 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Exelixis, Inc. (smg) |
| Jul 18, 2022 | 6 | Main Document (2) Docket Text: Summons Issued as to MSN Laboratories Private Limited on 7/18/2022; MSN Pharmaceuticals, Inc. on 7/18/2022. (Attachments: # (1) Summons Issued MSN Laboratories Private Limited)(smg) |
| Jul 18, 2022 | 6 | Summons Issued MSN Laboratories Private Limited (2) |
| Jul 18, 2022 | 1 | Complaint* (1) |
